Marx S J, Menczel J, Campbell G, Aurbach G D, Spiegel A M, Norton J A
Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892.
Clin Endocrinol (Oxf). 1991 Dec;35(6):521-6. doi: 10.1111/j.1365-2265.1991.tb00938.x.
We wished to determine whether there was size heterogeneity of the parathyroid glands in patients with familial multiple endocrine neoplasia type 1 (FMEN1) and primary hyperparathyroidism.
At the National Institutes of Health we performed a retrospective analysis of parathyroid gland volume either from initial or repeat parathyroid exploration.
We studied subjects with FMEN1 and primary hyperparathyroidism.
The parathyroid gland volume was estimated from recorded orthogonal diameters. Volume could also be estimated conservatively in many glands for which one or more diameters were not recorded. Reproducibility of volume measurements was tested with a series of clay gland models. Indices of variability (among glands at an operation or among replicate measurements of a clay model) were the ratio of maximum volume/minimum volume and the average standard deviation of the log volume.
The most complete data were from eight initial operations with three dimensions recorded for all four glands. Volume heterogeneity was indicated by the average ratio of 9.6 for the maximum/minimum gland volume within an operation. The size heterogeneity was even greater among other subgroups. For example, the average ratio of maximum/minimum gland volume within an operation was 17 among five initial operations with four glands removed, but lacking measurements of three dimensions for some glands. Little of this size heterogeneity could be attributed to measurement error since eight replicate measurements on a model gland yielded a maximum/minimum volume ratio of 1.45.
There is a wide heterogeneity in size of the parathyroid glands in the patients with FMEN1 and primary hyperparathyroidism.
我们希望确定1型多发性内分泌腺瘤病(FMEN1)合并原发性甲状旁腺功能亢进患者的甲状旁腺是否存在大小异质性。
在美国国立卫生研究院,我们对初次或再次甲状旁腺探查时甲状旁腺的体积进行了回顾性分析。
我们研究了FMEN1合并原发性甲状旁腺功能亢进的受试者。
甲状旁腺体积通过记录的正交直径估算。对于许多未记录一个或多个直径的腺体,也可保守地估算其体积。通过一系列黏土腺体模型测试体积测量的可重复性。变异性指标(同一手术中的腺体之间或黏土模型的重复测量之间)为最大体积/最小体积之比以及对数体积的平均标准差。
最完整的数据来自8例初次手术,所有4个腺体的三维数据均有记录。手术中最大/最小腺体体积的平均比值为9.6,表明存在体积异质性。其他亚组中的大小异质性更大。例如,在5例切除4个腺体的初次手术中,尽管部分腺体缺少三维测量数据,但手术中最大/最小腺体体积的平均比值为17。由于对一个模型腺体进行8次重复测量得到的最大/最小体积比值为1.45,因此这种大小异质性几乎不能归因于测量误差。
FMEN1合并原发性甲状旁腺功能亢进患者的甲状旁腺大小存在广泛的异质性。